U.S. federal trademark · Serial No. 97317740
Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals
Drugs and pharmaceuticals in the form of solids, namely, capsules, medicated candy, tablets and liquids for the treatment of flu, viral infections including Covid-19, bacterial infections, diabetes, cancer, HIV, ulcers, high blood pressure, high cholesterol, seizures, epilepsy, muscle and joint pain; Pharmaceutical preparations, namely, pills for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.